Highlights•We highlight polymeric materials used for long-acting intraocular drug
delivery.•We discuss design considerations for delivering small molecules and …

Uveitis associated with juvenile idiopathic arthritis (JIA) typically involves the anterior
chamber segment, follows an indolent chronic course, and presents a high rate of uveitic …

Purpose To test the hypothesis that adjunctive slow-release dexamethasone implant
(Ozurdex; Allergan Inc, Irvine, CA) can improve the outcomes of vitreoretinal surgery for …

Purpose To identify clinical outcomes and treatment patterns of intravitreal dexamethasone
implant (Ozurdex; Allergan, Inc) in noninfectious uveitis in the clinical setting. Design …

Macular edema (ME) may complicate anterior, intermediate, and posterior uveitis, which
may be because of various infectious, neoplastic or autoimmune etiologies. BRB breakdown …

Introduction: The review aims to discuss effects of vitrectomy on pharmacokinetics of anti-
vascular endothelial growth factor (anti-VEGF) agents, and attempt to provide treatment …

Uveitis, a group of conditions characterized by intraocular inflammation, is a major cause of
sight loss in the working population. Most uveitis seen in Western countries is noninfectious …

Macular edema (ME) represents the most common cause for visual loss among uveitis
patients. The management of uveitic macular edema (UME) may be challenging, due to its …

Background This retrospective study investigated the efficacy of tocilizumab (TCZ), a fully
humanized antibody that binds both to soluble and membrane bound IL-6 receptors, for the …

Diabetic macular edema (DME) is a chronic condition with a multifactorial pathogenesis.
Vascular endothelial growth factor (VEGF) and several inflammatory mediators are …